0 NASDAQ Companies - August 20, 2019Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business UpdateRead More
0 NASDAQ Companies - August 20, 2019Duluth Holdings Inc. to Report Second Quarter 2019 Financial Results on September 12Read More
0 NASDAQ Companies - August 20, 2019Outlook Therapeutics Completes Patient Enrollment for NORSE 1 a Phase 3 Clinical Trial for ONS-5010 in Wet AMDRead More
0 NASDAQ Companies - August 20, 2019Qumu to Present at the 8th Annual Gateway Conference on September 4, 2019Read More
0 NASDAQ Companies - August 20, 2019Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare ConferenceRead More
0 NASDAQ Companies - August 20, 2019Proofpoint to Offer $750 Million Convertible Senior Notes due 2024Read More
0 NASDAQ Companies - August 20, 2019BioXcel Therapeutics Announces Award of Grant by U.S. Department of Defense’s (“DoD”) Congressionally Directed Medical Research Programs (“CDMRP”) for Development of BXCL501Read More
0 NASDAQ Companies - August 20, 2019VirTra to Present at the 8th Annual Gateway Conference on September 5, 2019Read More
0 NASDAQ Companies - August 20, 2019Envision Solar Products Used by 9 of the Top 50 Fleets in the USARead More
0 TSX News - August 20, 2019Columbus Announces Closing of the First Tranche of Private PlacementRead More
